explore -WSS

explore

author：entertainment 2025-09-06 05:03:33 - browse：97933

Illustration of a hospital being handed from a doctor to a business person – politics and policy coverage from STAT — New guidelines from federal antitrust enforcers would have big implications on health care deals. Adobe

Health care companies trying to merge can expect tougher policing from the top federal antitrust agencies, according to a set of new draft guidelines released Wednesday.

The Department of Justice and Federal Trade Commission laid out 13 proposed guidelines detailing how they will judge whether proposed mergers and acquisitions are anticompetitive and should be challenged.

The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceutical companies, medical device firms, and numerous other entities occur almost weekly. Research has shown that health care’s highly concentrated markets are a major reason why prices and spending have soared for patients and taxpayers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： HHS's proposed rule does nothing to address the climate crisis

WSS

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Will the IRA bring competition to the biologics market?

Primary care doctor shortage won't be solved by free med school tuition

Crowdfunding for medical bills sidesteps core problem, author says

WATCH: Why do bright lights make us see spots?

As health system earnings go up, health insurance stocks go down

entertainment

explore

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

White House touts steps to stem shortages of cancer treatments

Hepatitis C has a cure — but many Americans still lack access to it

AI for drug discovery: Experts on separating hype from reality

Supreme Court strikes down use of affirmative action

Generate Biomedicines machine learning biotech raises $273M

Hollywood unions extend contract negotiations for actors

Acelyrin, a rare IPO success, stumbles in its first big test

As demand for Covid shots wanes, Moderna seeks its next success

Novel spinal cord stimulator treats paralysis without surgery

explore

FDA panel endorses Alnylam’s heart drug — after picking it apart

Will the IRA bring competition to the biologics market?

Most antidepressants don't work on kids, teens, study finds

As billionaires fund anti

The effects of a landmark ruling on DNA ownership are becoming clearer

FDA panel endorses Alnylam’s heart drug — after picking it apart

hotspot

entertainment

hotspot

focus